Neoadjuvant Selicrelumab, an Agonist CD40 Antibody, Induces Changes in the Tumor Microenvironment in Patients with Resectable Pancreatic Cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Neoadjuvant Selicrelumab, an Agonist CD40 Antibody, Induces Changes in the Tumor Microenvironment in Patients with Resectable Pancreatic Cancer

Published:2021-06-10 Issue:16 Volume:27 Page:4574-4586
ISSN:1078-0432
Container-title:Clinical Cancer Research
language:en
Short-container-title:Clin Cancer Res

Author:

Byrne Katelyn T.,Betts Courtney B.,Mick Rosemarie,Sivagnanam Shamilene,Bajor David L.^ORCID,Laheru Daniel A.^ORCID,Chiorean E. Gabriela^ORCID,O'Hara Mark H.,Liudahl Shannon M.^ORCID,Newcomb Craig,Alanio Cécile^ORCID,Ferreira Ana P.,Park Byung S.^ORCID,Ohtani Takuya,Huffman Austin P.,Väyrynen Sara A.^ORCID,Dias Costa Andressa,Kaiser Judith C.^ORCID,Lacroix Andreanne M.,Redlinger Colleen,Stern Martin,Nowak Jonathan A.,Wherry E. John,Cheever Martin A.,Wolpin Brian M.,Furth Emma E.,Jaffee Elizabeth M.^ORCID,Coussens Lisa M.^ORCID,Vonderheide Robert H.^ORCID

Funder

Stand Up To Cancer–Lustgarten Foundation Pancreatic Cancer Convergence Dream Team Translational Research Grant

Pancreatic Cancer Action Network

Lustgarten Foundation

NIH

Cancer Immunology Trials Network

Entertainment Industry Foundation

American Association for Cancer Research

SU2C

Parker Institute for Cancer Immunotherapy

Knight Cancer Institute

OHSU

Hale Center for Pancreatic Cancer Research

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 104 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The potential of biomimetic nanoparticles for macrophage repolarisation and phagocytosis in tumour immunotherapy;Chemical Engineering Journal;2024-10

2. Innate immune cells in tumor microenvironment: A new frontier in cancer immunotherapy;iScience;2024-09

3. Precision Targeting Strategies in Pancreatic Cancer: The Role of Tumor Microenvironment;Cancers;2024-08-19

4. Advancements in microenvironment-based therapies: transforming the landscape of multiple myeloma treatment;Frontiers in Oncology;2024-07-17

5. Panoramic tumor microenvironment in pancreatic ductal adenocarcinoma;Cellular Oncology;2024-07-15

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3